Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Value communications

- PMLiVE

Sanofi launches diabetes drug Lyxumia in the UK

Says drug could make multimillion pound savings for the NHS

- PMLiVE

Merck cuts outlook as Q1 sales fall

But new R&D chief highlights potential of company's near-term pipeline

- PMLiVE

Research Partnership appoints three new office heads

Expands on US west coast and in Boston

- PMLiVE

ACM Global Central Laboratory appoints Timo Jackle

He joins from Bausch & Lomb

- PMLiVE

GSK submits COPD drug in US and EU

Umeclidinium bromide intended as monotherapy for lung condition

- PMLiVE

EC launches €150m brain research fund

It will cover key areas of research, such as mental disorders, pain, epilepsy and paediatric conduct disorders

- PMLiVE

Court blocks EMA release of pharma company data

AbbVie and InterMune successfully challenge request for trial data for Humira and Esbriet

- PMLiVE

FDA approves drugs for rare genetic liver condition and to reverse anticoagulation

Raptor’s Procysbi and CSL Behring’s Kcentra recommended in US

- PMLiVE

Merck & Co and Pfizer join forces on diabetes candidate

Latest big pharma alliance involving an SGLT2 inhibitor

- PMLiVE

Pharma industry must listen to pharmacies

Closer relationship necessary to improve medicines optimisation says senior public health adviser

- PMLiVE

Pfizer cuts 2013 forecast after weak first quarter

Revenues down 9 per cent as key drugs face generic competition

- PMLiVE

FDA refuses to back Gilead’s two HIV drugs

Agency questions quality of testing procedures for elvitegravir and cobicistat

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links